Abstract
RTX is the first proven alternative to CYC for remission induction in severe GPA and MPA. RTX is the preferred agent for patients presenting with severe disease flares, and its use had become the de facto standard of care for patients with chronically relapsing refractory GPA. Its use in EGPA requires further investigation.
Original language | English (US) |
---|---|
Pages (from-to) | 15-23 |
Number of pages | 9 |
Journal | Current opinion in rheumatology |
Volume | 24 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2012 |
Keywords
- Antineutrophil cytoplasmic antibody
- Antineutrophil cytoplasmic antibody associated vasculitis
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
- Granulomatosis with polyangiitis (Wegener's granulomatosis)
- Microscopic polyangiitis
- Rituximab
- Vasculitis
ASJC Scopus subject areas
- Rheumatology